Bristol Myers Squibb clocked $10 million in sales for new schizophrenia drug Cobenfy in the fourth quarter of 2024, with the ...

The capsules should not be opened. You will start by taking a lower dose of Cobenfy for at least two days, and then your dose may be further increased over several days. Your doctor will help you ...

Bristol Myers Squibb CEO Chris Boerner described his company's new drug, Cobenfy, which can be used to treat psychiatric disorders like schizophrenia. He said the treatment is effective but doesn ...

Bristol Myers (BMY) new psychiatric drug Cobenfy is effective in treating schizophrenia without “the serious side effects’ of other older therapies, writes Julie Coleman for CNBC..Bristol ...

Sales of Cobenfy, a new mind-stabilizing medicine ... on an earnings call that the “launch is really off to a strong start” and the company has “made very good progress achieving our ...